FDA Inspection 1167329 — LGM Pharma, LLC

LGM Pharma, LLC — FEI 3006191612

The FDA completed an inspection of LGM Pharma, LLC on Apr 14, 2022 in Boca Raton, FL. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI)
End Date
Apr 14, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Boca Raton, FL (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.